Profile
Peter L.
Saltonstall is currently a Director at Trio Health Advisory Group, Inc. and a Director at Medical Device Innovation Consortium.
He was previously the President, Chief Executive Officer & Director at The National Organization for Rare Disorders, Inc.
Peter L. Saltonstall active positions
| Companies | Position | Start |
|---|---|---|
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Operates as trade association for processing, improving and advancing medical technologies | Director/Board Member | 2016-01-31 |
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Develops proprietary technology platform | Director/Board Member | - |
Former positions of Peter L. Saltonstall
| Companies | Position | End |
|---|---|---|
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Chief Executive Officer | 2024-04-30 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Develops proprietary technology platform | Technology Services |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Operates as trade association for processing, improving and advancing medical technologies | Commercial Services |
- Stock Market
- Insiders
- Peter L. Saltonstall
















